GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » EV-to-EBITDA

Healthlead PCL (BKK:HL) EV-to-EBITDA : 14.63 (As of Jun. 09, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Healthlead PCL's enterprise value is ฿2,523 Mil. Healthlead PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ฿172 Mil. Therefore, Healthlead PCL's EV-to-EBITDA for today is 14.63.

The historical rank and industry rank for Healthlead PCL's EV-to-EBITDA or its related term are showing as below:

BKK:HL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 13.77   Med: 32.37   Max: 49.09
Current: 14.64

During the past 5 years, the highest EV-to-EBITDA of Healthlead PCL was 49.09. The lowest was 13.77. And the median was 32.37.

BKK:HL's EV-to-EBITDA is ranked worse than
73.17% of 82 companies
in the Medical Distribution industry
Industry Median: 9.99 vs BKK:HL: 14.64

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-09), Healthlead PCL's stock price is ฿10.50. Healthlead PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ฿0.288. Therefore, Healthlead PCL's PE Ratio for today is 36.46.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Healthlead PCL EV-to-EBITDA Historical Data

The historical data trend for Healthlead PCL's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL EV-to-EBITDA Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - 32.45 33.25 15.69

Healthlead PCL Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.16 20.30 17.93 15.69 17.00

Competitive Comparison of Healthlead PCL's EV-to-EBITDA

For the Medical Distribution subindustry, Healthlead PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL's EV-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Healthlead PCL's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's EV-to-EBITDA falls into.



Healthlead PCL EV-to-EBITDA Calculation

Healthlead PCL's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2523.367/172.44
=14.63

Healthlead PCL's current Enterprise Value is ฿2,523 Mil.
Healthlead PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿172 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthlead PCL  (BKK:HL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Healthlead PCL's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.50/0.288
=36.46

Healthlead PCL's share price for today is ฿10.50.
Healthlead PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.288.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Healthlead PCL EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthlead PCL (BKK:HL) Business Description

Traded in Other Exchanges
N/A
Address
99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.